BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36933518)

  • 1. Association between endocrine therapy and cognitive decline in older women with early breast cancer: Findings from the prospective CLIMB study.
    Baltussen JC; Derks MGM; Lemij AA; de Glas NA; Fiocco M; Linthorst-Niers EMH; Vulink AJE; van Gerven L; Guicherit OR; van Dalen T; Merkus JWS; Lans TE; van der Pol CC; Mooijaart SP; Portielje JEA; Liefers GJ
    Eur J Cancer; 2023 May; 185():1-10. PubMed ID: 36933518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive effects of adjuvant endocrine therapy in older women treated for early-stage breast cancer: a 1-year longitudinal study.
    Underwood EA; Jerzak KJ; Lebovic G; Rochon PA; Elser C; Pritchard KI; Tierney MC
    Support Care Cancer; 2019 Aug; 27(8):3035-3043. PubMed ID: 30610433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal Associations Between Visual Impairment and Cognitive Functioning: The Salisbury Eye Evaluation Study.
    Zheng DD; Swenor BK; Christ SL; West SK; Lam BL; Lee DJ
    JAMA Ophthalmol; 2018 Sep; 136(9):989-995. PubMed ID: 29955805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal Maintenance of Cognitive Health in Centenarians in the 100-plus Study.
    Beker N; Sikkes SAM; Hulsman M; Tesi N; van der Lee SJ; Scheltens P; Holstege H
    JAMA Netw Open; 2020 Feb; 3(2):e200094. PubMed ID: 32101309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the Haptoglobin Gene Polymorphism With Cognitive Function and Decline in Elderly African American Adults With Type 2 Diabetes: Findings From the Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) Study.
    Beeri MS; Lin HM; Sano M; Ravona-Springer R; Liu X; Bendlin BB; Gleason CE; Guerrero-Berroa E; Soleimani L; Launer LJ; Ehrenberg S; Lache O; Seligman YK; Levy AP
    JAMA Netw Open; 2018 Nov; 1(7):e184458. PubMed ID: 30646354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive function assessed by Mini-mental state examination and risk of all-cause mortality: a community-based prospective cohort study.
    Su Y; Dong J; Sun J; Zhang Y; Ma S; Li M; Zhang A; Cheng B; Cai S; Bao Q; Wang S; Zhu P
    BMC Geriatr; 2021 Oct; 21(1):524. PubMed ID: 34600472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age, education, and changes in the Mini-Mental State Exam scores of older women: findings from the Nun Study.
    Butler SM; Ashford JW; Snowdon DA
    J Am Geriatr Soc; 1996 Jun; 44(6):675-81. PubMed ID: 8642159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cognitive effects of endocrine therapy in survivors of breast cancer: A prospective longitudinal study up to 6 years after treatment.
    Van Dyk K; Crespi CM; Bower JE; Castellon SA; Petersen L; Ganz PA
    Cancer; 2019 Mar; 125(5):681-689. PubMed ID: 30485399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive functioning and its associated factors among breast cancer patients on chemotherapy at Tikur Anbessa specialized hospital, Addis Ababa Ethiopia: an institution-based comparative cross-sectional study.
    Abebe E; Tollesa T; Assefa M; Tilahun Z; Dinku Y; Abebaw S; Mamuye M
    BMC Cancer; 2021 Sep; 21(1):1052. PubMed ID: 34563150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systolic Blood Pressure and Cognitive Decline in Older Adults With Hypertension.
    Streit S; Poortvliet RKE; Elzen WPJD; Blom JW; Gussekloo J
    Ann Fam Med; 2019 Mar; 17(2):100-107. PubMed ID: 30858252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Cognitive Assessment Following Acute Stroke: Feasibility and Comparison between Mini-Mental State Examination and Montreal Cognitive Assessment.
    Suda S; Muraga K; Ishiwata A; Nishimura T; Aoki J; Kanamaru T; Suzuki K; Sakamoto Y; Katano T; Nagai K; Hatake S; Satoi S; Matsumoto N; Nito C; Nishiyama Y; Mishina M; Kimura K
    J Stroke Cerebrovasc Dis; 2020 Apr; 29(4):104688. PubMed ID: 32063455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease.
    Faust-Socher A; Duff-Canning S; Grabovsky A; Armstrong MJ; Rothberg B; Eslinger PJ; Meaney CA; Schneider RB; Tang-Wai DF; Fox SH; Zadikoff C; Kennedy N; Chou KL; Persad C; Litvan I; Mast BT; Gerstenecker AT; Weintraub S; Reginold W; Marras C
    Dement Geriatr Cogn Disord; 2019; 47(4-6):187-197. PubMed ID: 31315127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure to ambient air pollution and cognitive decline: Results of the prospective Three-City cohort study.
    Duchesne J; Gutierrez LA; Carrière I; Mura T; Chen J; Vienneau D; de Hoogh K; Helmer C; Jacquemin B; Berr C; Mortamais M
    Environ Int; 2022 Mar; 161():107118. PubMed ID: 35147081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-sectional and longitudinal associations between adherence to Mediterranean diet with physical performance and cognitive function in older adults: A systematic review and meta-analysis.
    Coelho-Júnior HJ; Trichopoulou A; Panza F
    Ageing Res Rev; 2021 Sep; 70():101395. PubMed ID: 34153553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Gender-Affirming Hormone Therapy and Cognitive Functioning in Older Transgender Women Compared With Cisgender Women and Men.
    van Heesewijk JO; Dreijerink KMA; Wiepjes CM; Kok AAL; van Schoor NM; Huisman M; den Heijer M; Kreukels BPC
    J Sex Med; 2021 Aug; 18(8):1434-1443. PubMed ID: 34247950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of taxane-based chemotherapy among older women with breast cancer on cognition and quality of life: a longitudinal pooled analysis.
    Small BJ; Lange M; Zhai W; Ahn J; Ahles TA; Carroll JE; Cohen HJ; Graham D; Extermann M; Heutte N; Jim HSL; McDonald BC; Patel SK; Root JC; Saykin AJ; Van Dyk K; Zhou X; Mandelblatt J; Joly F;
    Breast Cancer Res Treat; 2022 Jan; 191(2):459-469. PubMed ID: 34817750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADAM10 plasma levels predict worsening in cognition of older adults: a 3-year follow-up study.
    Oliveira Monteiro MPA; Salheb Oliveira DSM; Manzine PR; Crispim Nascimento CM; Dos Santos Orlandi AA; de Oliveira Gomes GA; Dos Santos Orlandi F; Zazzetta MS; Pott-Junior H; Cominetti MR
    Alzheimers Res Ther; 2021 Jan; 13(1):18. PubMed ID: 33419480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letter Re: Association between endocrine therapy and cognitive decline in older women with early breast cancer: Findings from the prospective CLIMB study.
    Chen H; Feng L
    Eur J Cancer; 2023 Sep; 191():113239. PubMed ID: 37550125
    [No Abstract]   [Full Text] [Related]  

  • 19. Baseline Mobility is Not Associated with Decline in Cognitive Function in Healthy Community-Dwelling Older Adults: Findings From The Irish Longitudinal Study on Ageing (TILDA).
    Donoghue O; Feeney J; O'Leary N; Kenny RA
    Am J Geriatr Psychiatry; 2018 Apr; 26(4):438-448. PubMed ID: 29275903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of chemotherapy on cognitive functioning in older patients with HER2-positive breast cancer: a sub-study in the RESPECT trial.
    Hagiwara Y; Sawaki M; Uemura Y; Kawahara T; Shimozuma K; Ohashi Y; Takahashi M; Saito T; Baba S; Kobayashi K; Mukai H; Taira N
    Breast Cancer Res Treat; 2021 Aug; 188(3):675-683. PubMed ID: 34080094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.